Atomoxetine
Treatment for Adhd
Typical Dosage: 40-100mg daily
Effectiveness
60%
Safety Score
65%
Clinical Trials
136
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
40-100mg daily
Time to Effect
2-4 weeks for initial effects, 6-12 weeks for full effect
Treatment Duration
Long-term (as needed)
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$600
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$21,250/QALY
QALYs Gained
0.04
Outcome-Based Costs
Cost per Responder
$1,888.89
Cost per Remission
$4,250
Atomoxetine Outcomes
for Adhd
Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+45%
Remission Rate
+20%
Common Side Effects
Nausea/vomiting/abdominal pain
+15%
Insomnia
+12%
Dry mouth
+10%
Headache
+10%
Decreased appetite
+8%
Increased heart rate/blood pressure
+5%
Sources:
Active Clinical Trials
1 active trial recruiting for Atomoxetine in Adhd
Role of Coenzyme Q in ADHD in Children
NCT04216186RECRUITINGPHASE3
40 participants
INTERVENTIONAL
Tanta, Egypt
Started: Nov 1, 2018
Completed Clinical Trials
16 completed trials for Atomoxetine in Adhd
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
NCT00181766COMPLETEDPHASE4
45 participants
INTERVENTIONAL
Cambridge, United States
Started: Dec 1, 2003
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
NCT00181948COMPLETEDPHASE4
30 participants
INTERVENTIONAL
Cambridge, United States
Started: Sep 1, 2004
Atomoxetine PBPK-PD Clinical Study
NCT03154359COMPLETED
51 participants
OBSERVATIONAL
Kansas City, United States
Started: Dec 12, 2017
Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00568685COMPLETEDPHASE3
153 participants
INTERVENTIONAL
Bucheon-si, South Korea +2 more
Started: Nov 1, 2007
Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD
NCT03661788COMPLETEDPHASE4
38 participants
INTERVENTIONAL
Aachen, Germany
Started: May 1, 2016
Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00636818COMPLETEDPHASE2
45 participants
INTERVENTIONAL
Beijing, China +10 more
Started: Mar 1, 2008
Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00320528COMPLETEDPHASE3
269 participants
INTERVENTIONAL
Acireale, Italy +19 more
Started: Apr 1, 2006
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
NCT00417794COMPLETEDPHASE1
38 participants
INTERVENTIONAL
Oklahoma City, United States
Started: Aug 1, 2005
A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
NCT00471354COMPLETEDPHASE4
228 participants
INTERVENTIONAL
Beijing, China +7 more
Started: Apr 1, 2007
Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
NCT00760747COMPLETEDPHASE4
112 participants
INTERVENTIONAL
Milton, Australia +5 more
Started: Sep 1, 2008
Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
NCT00190736COMPLETEDPHASE4
440 participants
INTERVENTIONAL
Lafayette, United States +18 more
Started: Sep 1, 2004
A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
NCT00969618COMPLETEDPHASE3
211 participants
INTERVENTIONAL
Aichi, Japan +11 more
Started: Nov 1, 2009
Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00530335COMPLETEDPHASE2
45 participants
INTERVENTIONAL
Aichi, Japan +11 more
Started: Sep 1, 2007
Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine
NCT00938743COMPLETEDPHASE4
50 participants
INTERVENTIONAL
Mannheim, Germany
Started: Jan 1, 2008
Long-Term, Open Label Atomoxetine Study
NCT00190684COMPLETEDPHASE3
1.55K participants
INTERVENTIONAL
Birmingham, United States +99 more
Started: Aug 1, 2000
Concerta Treatment in Adults With ADHD NOS
NCT00181740COMPLETEDPHASE4
30 participants
INTERVENTIONAL
Cambridge, United States
Started: Dec 1, 2003
Showing 20 of 136 total trials